Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

ChartMaxx® Earns 2013 'Best in KLAS' for Healthcare DMI Software Products

Published: Thursday, February 06, 2014
Last Updated: Thursday, February 06, 2014
Bookmark and Share
ChartMaxx enterprise content management system honored with top ranking for the ninth time.

Quest Diagnostics has announced that its ChartMaxx® enterprise content management technology (ECM) solution was ranked the top healthcare Document Management and Imaging (DMI) software product, according to the 2013 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information technology (HIT) providers. ChartMaxx secured the highest overall score and product quality rating in the DMI category.

2013 marks the ninth time ChartMaxx has ranked in the Best in KLAS survey, making it the most frequently awarded product in the DMI category. DMI software is used to scan, create, archive, streamline workflows and validate electronically stored documents and images for hospitals and health organizations to complement their EHR, enterprise resource planning (ERP), and financial systems where additional enterprise data needs to be captured and accessed for better patient care.

"We listened to the providers, and these are the results," said Adam Gale, CEO and president of KLAS Research. "This report isn't about KLAS. It is a reflection of thousands of providers who wanted to be heard and counted. That is the reason top-performing vendors should be proud of their achievements."

The ChartMaxx product suite has helped more than 170 healthcare providers improve their enterprise health document management for more than 15 years, enabling healthcare organizations to enhance workflow performance through the efficient collection of enterprise content from clinical, financial, human resources and administrative information.

Quest's award-winning implementation, integration, consulting and process re-engineering services in support of ChartMaxx help healthcare organizations define, streamline and automate departmental workflows, improving efficiencies as well as clinical care.

"The ChartMaxx solution provides significant value to physicians, hospital administrators and CIOs requiring an intuitive, enterprise-wide solution for their healthcare document and data management needs," said Philip Present, vice president and general manager, Quest Diagnostics Care360 and ChartMaxx Products. "As healthcare becomes increasingly data driven, hospitals and physicians need interoperable solutions that capture and showcase the entire medical record to help them make informed clinical decisions and enhance the patient experience."

Added Mr. Present: "The Best in KLAS distinction is more than an affirmation of our commitment to providing solutions, support, and services that delight our customers. We believe it reflects Quest's ability to create innovative solutions to help healthcare professionals use diagnostic insights and other healthcare information to improve patient care."

ChartMaxx will be showcased at the Quest Diagnostics exhibit (3064) during the 2014 HIMSS Conference & Exhibition, February 23-27, in Orlando.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Quest Diagnostics to Acquire Laboratory Outreach Service Business
Transaction to extend laboratory partnership serving patients and physicians in Southern California while bolstering Quest's growth strategy in the region.
Wednesday, July 01, 2015
Quest Diagnostics Named "Most Admired Company"
Company earns Fortune Magazine 2015 "World's Most Admired Companies" designation by Fortune Magazine.
Tuesday, February 24, 2015
Quest Diagnostics and CDC Expand Public Health Collaboration
Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitis.
Thursday, January 29, 2015
FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test
Test kit with eight additional strains is now available directly in the United States.
Wednesday, December 10, 2014
Quest Diagnostics Adds Jeffrey M. Leiden to Board of Directors
Dr. Leiden has more than 20 years of scientific and commercial experience in the pharmaceutical and biotechnology industries.
Saturday, October 25, 2014
Quest Diagnostics Unveils New Clinical Laboratory in Marlborough, Massachusetts
Medical experts from UMass Memorial Medical Group and the University of Massachusetts to provide scientific leadership for testing onsite.
Tuesday, October 07, 2014
More People Testing Positive for Chikungunya Virus in the U.S.
Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year.
Friday, September 12, 2014
Quest Diagnostics Adds Vicky Gregg to Board of Directors
Company’s Board of Directors expand the Board to 10 members.
Friday, July 25, 2014
Quest Diagnostics Completes Acquisition of Summit Health
Summit's clients will access Quest's 2,200 patient service centers, biometric analysis.
Wednesday, April 23, 2014
Quest Diagnostics Elects Director
Quest Diagnostics announce that its Board of Directors has elected Timothy L. Main to serve as a director, effective immediately.
Tuesday, January 14, 2014
UC San Francisco and Quest Diagnostics Launch Collaboration
Collaboration to advance the field of precision medicine.
Friday, January 10, 2014
Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health
Acquisition consistent with strategy to drive one to two percent in growth per year through strategically aligned fold-in acquisitions.
Friday, July 05, 2013
Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
Company has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
Wednesday, April 10, 2013
Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
In this role, Dr. Nagendran will provide medical oversight for the company's diagnostic information services.
Thursday, April 04, 2013
Federal Guidelines Recommend New HIV Testing Method
U.S. Department of Health and Human Services issues medical guidelines recommending genotypic testing to aid HIV therapy selection.
Thursday, March 28, 2013
Scientific News
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Biomarker Finder Adjusts On the Fly
Rice University scientists build better tool to find signs of disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos